Cancer Cachexia – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033
Cancer cachexia is a debilitating wasting syndrome typified by weight loss, anorexia, asthenia, and anemia. In cancer patients, the manifestations of cachexia serve as prognostic indicators, reflecting the severity of the disease. The pathogenesis of this syndrome is multifaceted due to intricate interactions between tumor and host factors. Anorexia, characterized by a loss of appetite or diminished desire to eat, plays a pivotal role in inducing weight loss associated with cancer cachexia. Notably, this phenomenon is distinct from the effects of chemotherapy. Current treatment approaches primarily focus on appetite stimulation, targeting cachetic signaling molecules and mediators to mitigate wasting. Strategies encompass central and peripheral appetite stimulants and nutritional supplements, including omega-3 fatty acids and essential amino acids, to counteract weight loss and anorexia. Thelansis’s “Cancer Cachexia Market Outlook, Epidemiology, Competitive Landscape, and M...